Drug Trial Radar · NCT00666575
A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness
Last checked: Nov 19, 2026Latest source record: Feb 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,105
Planned (sponsor's estimate)
Start
Dec 2004
Primary completion
Not stated
Study completion May 2005
Sponsor
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Pfizer (PFE)
- Sponsor type
- Industry
- First posted
- Apr 25, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety of gabapentin, as compared to placebo, in a potential over-the-counter population with reports of occasional sleeplessness
Conditions
- Transient Insomnia
Interventions
GabapentinDrug
Gabapentin 500 mg oral capsule 30 minutes prior to bedtime for 28 days
PlaceboDrug
Matched placebo oral capsule 30 minutes prior to bedtime for 28 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse EventsTime frame: Day 45
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Pfizer Investigational Site
Mobile, Alabama
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Beverly Hills, California
Pfizer Investigational Site
San Francisco, California
Pfizer Investigational Site
Clearwater, Florida
Pfizer Investigational Site
DeLand, Florida
Pfizer Investigational Site
New Port Richey, Florida
Pfizer Investigational Site
Pembroke Pines, Florida
Pfizer Investigational Site
West Palm Beach, Florida
Pfizer Investigational Site
Atlanta, Georgia
Pfizer Investigational Site
Boise, Idaho
Pfizer Investigational Site
Boise, Idaho
Pfizer Investigational Site
Indianapolis, Indiana
Pfizer Investigational Site
Las Vegas, Nevada
Pfizer Investigational Site
Las Vegas, Nevada
Pfizer Investigational Site
Santa Fe, New Mexico
Pfizer Investigational Site
Nashville, Tennessee
Pfizer Investigational Site
Austin, Texas
Pfizer Investigational Site
Fort Worth, Texas
Pfizer Investigational Site
San Antonio, Texas
Pfizer Investigational Site
San Antonio, Texas
Pfizer Investigational Site
Salt Lake City, Utah
Pfizer Investigational Site
West Jordan, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.